Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2013

Open Access 01-07-2013 | Epidemiology

Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

Authors: Herbert Cubasch, Maureen Joffe, Rachel Hanisch, Joachim Schuz, Alfred I. Neugut, Alan Karstaedt, Nadine Broeze, Eunice van den Berg, Valerie McCormack, Judith S. Jacobson

Published in: Breast Cancer Research and Treatment | Issue 1/2013

Login to get access

Abstract

In the low-income HIV-endemic regions of sub-Saharan Africa, malignancies related to HIV have long been recognized as a major public health problem. However, epithelial malignancies associated with older age, such as breast cancer, are also rising dramatically in those regions. We compared consecutive HIV-positive and -negative black women diagnosed with breast cancer at a large public hospital in Soweto, South Africa, on age, year of diagnosis, stage, grade, and receptor status, and grouped HIV-positive patients by CD4 cell counts. We computed prevalence ratios of the associations of HIV status and CD4 category with stage, grade, receptor status, and among the HIV-positive patients, receipt of ART, controlling for age and year of diagnosis. Of 1,092 patients, 765 were tested for HIV; 151 (19.7 %) tested positive, a prevalence similar to that in the source population. Although, HIV-positive patients were younger than HIV-negative patients (p < 0.001), HIV status was not associated with the tumor characteristics. Thirty-seven women (25.9 %) had CD4 cell counts <200 cells/μl. Patients in that severely immunocompromised group were older than those in the other groups (p = 0.01). This study is the first to analyze the association of HIV with breast cancer in a large sample. Based on similar HIV prevalence in our sample and the population of the hospital’s catchment area, clinicians serving HIV-endemic communities should promote routine HIV testing of younger breast cancer patients and immediate treatment of those who test positive, prior to the initiation of chemotherapy. Research is needed on treatment and outcomes given HIV and low CD4 cell count.
Literature
1.
go back to reference Sankaranarayanan R, Swaminathan R, Lucas E (eds) (2011) Cancer survival in Africa, Asia, the Caribbean, and Central America. IARC, 305 p, ISBN 978-92-832-2162-3 Sankaranarayanan R, Swaminathan R, Lucas E (eds) (2011) Cancer survival in Africa, Asia, the Caribbean, and Central America. IARC, 305 p, ISBN 978-92-832-2162-3
2.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917PubMedCrossRef
4.
go back to reference Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D et al (2000) The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88(3):489–492PubMedCrossRef Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D et al (2000) The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88(3):489–492PubMedCrossRef
5.
go back to reference Amir H, Shibata HR, Kitinya JN, Kwesigabo G (1994) HIV-1 associated Kaposi’s sarcoma in an African population. Can J Oncol 4(4):302–306PubMed Amir H, Shibata HR, Kitinya JN, Kwesigabo G (1994) HIV-1 associated Kaposi’s sarcoma in an African population. Can J Oncol 4(4):302–306PubMed
6.
go back to reference Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Curr Opin Oncol 5(5):822–830PubMedCrossRef Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Curr Opin Oncol 5(5):822–830PubMedCrossRef
7.
go back to reference Frisch M, Biggar R, Engels E, Goedert J, Group A-CMRS (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13):1736–1745PubMedCrossRef Frisch M, Biggar R, Engels E, Goedert J, Group A-CMRS (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13):1736–1745PubMedCrossRef
8.
go back to reference Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM et al (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21(18):3447–3453PubMedCrossRef Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM et al (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21(18):3447–3453PubMedCrossRef
9.
go back to reference Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA, Study HACM (2006) Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 95(5):642–648PubMedCrossRef Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA, Study HACM (2006) Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 95(5):642–648PubMedCrossRef
10.
go back to reference Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118(4):985–990PubMedCrossRef Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118(4):985–990PubMedCrossRef
11.
go back to reference Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT (2008) Investigators AaASoDPaHOS: incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 148(10):728–736PubMedCrossRef Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT (2008) Investigators AaASoDPaHOS: incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 148(10):728–736PubMedCrossRef
12.
go back to reference Shiels MS, Cole SR, Kirk GD, Poole C (2009) A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 52(5):611–622PubMedCrossRef Shiels MS, Cole SR, Kirk GD, Poole C (2009) A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 52(5):611–622PubMedCrossRef
13.
go back to reference Endo M, Inatsu A, Hashimoto K, Takamune N, Shoji S, Misumi S (2008) Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4. Curr HIV Res 6(1):34–42PubMedCrossRef Endo M, Inatsu A, Hashimoto K, Takamune N, Shoji S, Misumi S (2008) Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4. Curr HIV Res 6(1):34–42PubMedCrossRef
14.
go back to reference Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D’Souza G et al (2010) HIV tropism and decreased risk of breast cancer. PLoS ONE 5(12):e14349PubMedCrossRef Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D’Souza G et al (2010) HIV tropism and decreased risk of breast cancer. PLoS ONE 5(12):e14349PubMedCrossRef
15.
go back to reference Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9(8):859–866PubMedCrossRef Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9(8):859–866PubMedCrossRef
16.
go back to reference Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183–188PubMedCrossRef Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183–188PubMedCrossRef
17.
go back to reference Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Goodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O’Regan RM et al (2009) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 113(1):189–196PubMedCrossRef Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Goodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O’Regan RM et al (2009) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 113(1):189–196PubMedCrossRef
18.
go back to reference Owens MA, Horten BC, Da Silva MM (2004) HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer 5(1):63–69PubMedCrossRef Owens MA, Horten BC, Da Silva MM (2004) HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer 5(1):63–69PubMedCrossRef
19.
go back to reference Glencross D, Scott LE, Jani IV, Barnett D, Janossy G (2002) CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50(2):69–77PubMedCrossRef Glencross D, Scott LE, Jani IV, Barnett D, Janossy G (2002) CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50(2):69–77PubMedCrossRef
20.
go back to reference Thompson ML, Myers JE, Kriebel D (1998) Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med 55(4):272–277PubMedCrossRef Thompson ML, Myers JE, Kriebel D (1998) Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med 55(4):272–277PubMedCrossRef
21.
go back to reference Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3:21PubMedCrossRef Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3:21PubMedCrossRef
22.
go back to reference Linas BS, Minkoff H, Cohen MH, Karim R, Cohan D, Wright RL, Young M, Watts DH, Golub ET (2011) Relative time to pregnancy among HIV-infected and uninfected women in the Women’s Interagency HIV Study, 2002–2009. AIDS 25(5):707–711PubMedCrossRef Linas BS, Minkoff H, Cohen MH, Karim R, Cohan D, Wright RL, Young M, Watts DH, Golub ET (2011) Relative time to pregnancy among HIV-infected and uninfected women in the Women’s Interagency HIV Study, 2002–2009. AIDS 25(5):707–711PubMedCrossRef
23.
go back to reference Shim JS, Rao R, Beebe K, Neckers L, Han I, Nahta R, Liu JO (2012) Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. J Natl Cancer Inst 104(20):1576–1590CrossRef Shim JS, Rao R, Beebe K, Neckers L, Han I, Nahta R, Liu JO (2012) Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. J Natl Cancer Inst 104(20):1576–1590CrossRef
24.
go back to reference Spano JP, Lanoy E, Mounier N, Katlama C, Costagliola D, Heard I (2012) Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications. Eur J Cancer 48(18):3335–3341PubMedCrossRef Spano JP, Lanoy E, Mounier N, Katlama C, Costagliola D, Heard I (2012) Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications. Eur J Cancer 48(18):3335–3341PubMedCrossRef
25.
go back to reference Latif N, Rana F, Guthrie T (2011) Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature. Breast J 17(1):87–92PubMedCrossRef Latif N, Rana F, Guthrie T (2011) Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature. Breast J 17(1):87–92PubMedCrossRef
Metadata
Title
Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa
Authors
Herbert Cubasch
Maureen Joffe
Rachel Hanisch
Joachim Schuz
Alfred I. Neugut
Alan Karstaedt
Nadine Broeze
Eunice van den Berg
Valerie McCormack
Judith S. Jacobson
Publication date
01-07-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2606-y

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine